
Ela Pharma is driven to create novel therapeutics for better patient recovery and care, in the most pressing clinical applications such as organ preservation, retinal artery occlusion, acute ischemic conditions and acute liver failure. Our proprietary technology is based on small molecules to inhibit intracellular proteolytic enzymes targeting novel anti-necrotic based pathways.
Annual RevenueBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.